| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 09/30/2004 | WO2004083381A2 Fibroblast growth factor receptor-1 polynucleotides, polypeptides, and mutants |
| 09/30/2004 | WO2004083379A2 Large volume ex vivo electroporation method |
| 09/30/2004 | WO2004083378A2 Mammalian cell lines specifically deficient in o-linked glycosylation |
| 09/30/2004 | WO2004083377A2 Microorganism-templated nanoparticle assembly |
| 09/30/2004 | WO2004083375A2 Methods of promoting the differentiation of stem cells |
| 09/30/2004 | WO2004083372A2 Modulators of the notch signaling pathway immobilized on particles for modifying immune responses |
| 09/30/2004 | WO2004083366A2 Methods utilizing novel target genes related to immune-mediated diseases |
| 09/30/2004 | WO2004074445A9 Model for studying the role of genes in tumor resistance to chemotherapy |
| 09/30/2004 | WO2004065578A3 Microparticles comprising polynucleotide adsorbed on the surface of or entrapped within the microparticles |
| 09/30/2004 | WO2004048532A3 Inferring gene regulatory networks from time-ordered gene expression data using differential equations |
| 09/30/2004 | WO2003048332A3 METHODS FOR ANALYZING METHYLATED CpG ISLANDS AND GC RICH REGIONS |
| 09/30/2004 | US20040191877 lovE variant regulator molecules |
| 09/30/2004 | US20040191873 Determining transcription profile for cell with simultaneous identification of intron/exon boundaries; functional genomics and transcriptomics |
| 09/30/2004 | US20040191843 Cytotoxic mixture comprising polypeptides for treatment and prevention of cell proliferfative disorders |
| 09/30/2004 | US20040191538 Nanometer-controlled polymeric thin films that resist adsorption of biological molecules and cells |
| 09/30/2004 | CA2520629A1 Methods of promoting the differentiation of stem cells |
| 09/30/2004 | CA2519456A1 Aberrantly methylated genes in pancreatic cancer |
| 09/30/2004 | CA2519084A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 09/30/2004 | CA2519071A1 Targeted and regional cellular ablation in zebrafish |
| 09/30/2004 | CA2519065A1 Large volume ex vivo electroporation method |
| 09/30/2004 | CA2518924A1 Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv |
| 09/30/2004 | CA2518555A1 Separation and accumulation of subcellar components, and proteins derived therefrom |
| 09/29/2004 | EP1461464A1 A method for identifying markers |
| 09/29/2004 | EP1461456A2 Methods for the identification of genetic features for complex genetics classifiers |
| 09/29/2004 | EP1461052A2 Nucleic acid injected into hepatic vein lumen and delivered to primate liver |
| 09/29/2004 | EP0980426B1 TYROSINE PHOSPHORYLATED CLEAVAGE FURROW-ASSOCIATED PROTEINS (PSTPIPs) |
| 09/29/2004 | EP0699079B1 Bioactive and/or targeted dendrimer conjugates comprising genetic materials |
| 09/29/2004 | CN1533434A Inflenza vaccine composition |
| 09/29/2004 | CN1533433A Method for virus propagation |
| 09/23/2004 | WO2004081199A2 Novel compositions and methods for the treatment of immune related disease |
| 09/23/2004 | WO2004081198A2 Methods for modulating angiogenesis with apelin compositions |
| 09/23/2004 | WO2004081197A2 Immune response associated proteins |
| 09/23/2004 | WO2004081196A2 Formulations for cell- schedule dependent anticancer agents |
| 09/23/2004 | WO2004081195A2 Use of secretin and secretin analogs to treat affective disorders |
| 09/23/2004 | WO2004081194A2 Approaches to identifying genetic traits in animals |
| 09/23/2004 | WO2004081193A2 Method for producing ethanol using raw starch |
| 09/23/2004 | WO2004081191A2 Molecular haplotyping of genomic dna |
| 09/23/2004 | WO2004081189A2 Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and organisms |
| 09/23/2004 | WO2004081188A2 Non-toxic membrane-translocating peptides |
| 09/23/2004 | WO2004081187A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 09/23/2004 | WO2004081185A2 Methods to enhance the activity of lignocellulose-degrading enzymes |
| 09/23/2004 | WO2004081184A2 Markerless transformation |
| 09/23/2004 | WO2004081183A2 In vitro dna immortalization and whole genome amplification using libraries generated from randomly fragmented dna |
| 09/23/2004 | WO2004081182A2 Compositions and methods for polynucleotide sequence detection |
| 09/23/2004 | WO2004081181A2 Method for determining susceptibility of tumor to treatment with anti-neoplastic agent |
| 09/23/2004 | WO2004081180A2 Crystals and structures of ephrin reception epha7 |
| 09/23/2004 | WO2004081179A2 Regulation of rna stability |
| 09/23/2004 | WO2004081178A2 Methods and composition for producing infectious hpv stocks |
| 09/23/2004 | WO2004081177A2 Intracellular signaling pathways in diabetic subjects |
| 09/23/2004 | WO2004081175A2 Methods and compositions for purification of nucleic acid from a host cell |
| 09/23/2004 | WO2004081174A2 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker |
| 09/23/2004 | WO2004081173A2 Nucleotide sequences regulating gene expression and constructs and methods utilizing same |
| 09/23/2004 | WO2004081171A2 Variants of enzymes of the alpha-amylase family |
| 09/23/2004 | WO2004081167A2 Expression vectors comprising the mcmv ie2 promoter |
| 09/23/2004 | WO2004081165A2 Novel purified dihydrodipicolinate synthase polypeptides and structures thereof |
| 09/23/2004 | WO2004016751A3 Methods of treating neurodegenerative diseases |
| 09/23/2004 | WO2003100032A3 Dwarfism genes and dwarf plants |
| 09/23/2004 | WO2003085096A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/23/2004 | WO2003046136A3 Single tube screen |
| 09/23/2004 | US20040186054 Angiopoietin and fragments, mutants, and analogs thereof and uses of the same |
| 09/23/2004 | US20040185063 Solution comprising water, alcohol, and homogenously dispersed Chlorella diatoms of small particle size; mercury or heavy metal removal in patients; demetallization |
| 09/23/2004 | DE10310261A1 Identifizierung von Antigen-Epitopen Identification of antigen epitopes |
| 09/23/2004 | CA2518957A1 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 09/23/2004 | CA2518904A1 Molecular haplotyping of genomic dna |
| 09/23/2004 | CA2518814A1 Approaches to identifying genetic traits in animals |
| 09/23/2004 | CA2518791A1 Formulations for cell-schedule dependent anticancer agents |
| 09/23/2004 | CA2518552A1 Novel compositions and methods for the treatment of immune related disease |
| 09/23/2004 | CA2518144A1 Methods to enhance the activity of lignocellulose-degrading enzymes |
| 09/23/2004 | CA2516306A1 Compositions and methods for polynucleotide sequence detection |
| 09/22/2004 | EP0636179B1 Oil-body proteins as carriers of high-value peptides in plants |
| 09/16/2004 | WO2004078985A1 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/16/2004 | WO2004078984A1 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/16/2004 | WO2004078950A2 METHODS AND COMPOSITIONS FOR SELECTIVE RNAi MEDIATED INHIBITION OF GENE EXPRESSION IN MAMMAL CELLS |
| 09/16/2004 | WO2004078948A2 METHOD TO IDENTIFY REGULATORS OF CELLULAR ACTIVATION USING Bcl10 |
| 09/16/2004 | WO2004078943A2 Alternative heterocycles for dna recognition |
| 09/16/2004 | WO2004078940A2 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF eIF-5A1 |
| 09/16/2004 | WO2004078939A2 REGULATION OF Mdm2 FUNCTION |
| 09/16/2004 | WO2004078936A2 Methods for preventing gluconoylation of proteins |
| 09/16/2004 | WO2004078935A2 Removal of plastid sequences by transiently expressed site-specific recombinases |
| 09/16/2004 | WO2004078934A2 Targeting site-2 protease (s2p) for the treatment of pancreatic cancer |
| 09/16/2004 | WO2004078933A2 Intracellular delivery of small molecules proteins and nucleic acids |
| 09/16/2004 | WO2004078932A2 Methods and systems for preparing virtual representations of molecules |
| 09/16/2004 | WO2004078930A2 Nanometer-controlled polymeric thin films that resist adsorption of biological molecules and cells |
| 09/16/2004 | WO2004078929A2 Materials and methods for identifying genes and/or agents that alter replicative lifespan |
| 09/16/2004 | WO2004078928A2 T cell regulation |
| 09/16/2004 | WO2004078926A2 Immunologigal markers |
| 09/16/2004 | WO2004078925A2 Methods and compositions for treating and preventing neurodegenerative diseases |
| 09/16/2004 | WO2004078924A2 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 09/16/2004 | WO2004078923A2 Pyk2 crystal structure and uses |
| 09/16/2004 | WO2004078922A2 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 09/16/2004 | WO2004078919A2 Superactive cellulase formulation using cellobiohydrolase-1 from penicillium funiculosum |
| 09/16/2004 | WO2004078918A2 Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides |
| 09/16/2004 | WO2004078916A2 In vitro micro-organs, and uses related thereto |
| 09/16/2004 | WO2004078911A2 T-cell transformation by recombinant hvs subgroup c |
| 09/16/2004 | WO2004078909A2 Identification of antigen epitopes |
| 09/16/2004 | WO2004078906A2 Method for producing a immobilised virus carrier and the use thereof |
| 09/16/2004 | WO2004078905A2 Agents for phytoremediation |
| 09/16/2004 | WO2004072227A3 Animal testing procedure |
| 09/16/2004 | WO2004067714A3 Process and apparatus for microwave desorption of elements or species from carbon nanotubes |
| 09/16/2004 | WO2004022721A3 Quantification of gene expression |